citalopram has been researched along with dextromethorphan in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Baumann, P; Eap, CB; Hemmeter, U; Holsboer-Trachsler, E; Seifritz, E | 1 |
Amey, M; Baettig, D; Baumann, P; Jonzier-Perey, M; Kasas, A; Lambert, S; Montaldi, S; Nil, R; Souche, A; Uehlinger, C | 1 |
Brooks, DE; Pizon, AF; Schwartz, AR | 1 |
Barbera, N; Busardò, FP; Indorato, F; Romano, G | 1 |
Ihenetu, K; Na, S; Rosano, TG; Swift, TA; Wood, M | 1 |
Antonsdottir, IM; Keltz, M; Porsteinsson, AP; Smith, J | 1 |
Batsikadze, G; Jamil, A; Kuo, HI; Kuo, MF; Nitsche, MA; Paulus, W | 1 |
Arcega, V; Dy, P; Ghali, W; Wolfe, W | 1 |
Baumann, P; Bertschy, G; Nil, R; Ramseier, F | 1 |
2 review(s) available for citalopram and dextromethorphan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Advancements in the treatment of agitation in Alzheimer's disease.
Topics: Alzheimer Disease; Cannabinoid Receptor Agonists; Cannabinoids; Citalopram; Clinical Trials, Phase III as Topic; Dextromethorphan; Drug Combinations; Humans; Psychomotor Agitation; Quinidine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2015 |
2 trial(s) available for citalopram and dextromethorphan
Article | Year |
---|---|
A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation.
Topics: Adult; Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Depressive Disorder; Dextromethorphan; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Mephenytoin; Middle Aged; Mixed Function Oxygenases; Selective Serotonin Reuptake Inhibitors | 1996 |
Chronic Enhancement of Serotonin Facilitates Excitatory Transcranial Direct Current Stimulation-Induced Neuroplasticity.
Topics: Adult; Citalopram; Cross-Over Studies; Dextromethorphan; Double-Blind Method; Evoked Potentials, Motor; Excitatory Amino Acid Antagonists; Female; Humans; Male; Motor Cortex; Neuronal Plasticity; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Serotonin; Transcranial Direct Current Stimulation; Young Adult | 2016 |
9 other study(ies) available for citalopram and dextromethorphan
Article | Year |
---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Increased trimipramine plasma levels during fluvoxamine comedication.
Topics: Aged; Citalopram; Depressive Disorder; Dextromethorphan; Drug Interactions; Female; Fluvoxamine; Humans; Mephenytoin; Phenotype; Trimipramine | 1994 |
Dextromethorphan-induced serotonin syndrome.
Topics: Antitussive Agents; Child; Citalopram; Dextromethorphan; Drug Interactions; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Treatment Outcome; Young Adult | 2008 |
The pathogenetic role of adulterants in 5 cases of drug addicts with a fatal outcome.
Topics: Adult; Anesthetics, Local; Antitussive Agents; Bile; Brain Chemistry; Caffeine; Central Nervous System Stimulants; Citalopram; Codeine; Dextromethorphan; Drug Contamination; Drug Overdose; Drug Users; Female; Forensic Pathology; Forensic Toxicology; Gastrointestinal Contents; Humans; Illicit Drugs; Kidney; Lidocaine; Liver; Lung; Male; Methadone; Morphine; Morphine Derivatives; Narcotics; Pyrrolidines; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Vitreous Body | 2013 |
Multi-drug and metabolite quantification in postmortem blood by liquid chromatography-high-resolution mass spectrometry: comparison with nominal mass technology.
Topics: Blood Chemical Analysis; Chromatography, High Pressure Liquid; Chromatography, Liquid; Citalopram; Cocaine; Codeine; Dextromethorphan; Diphenhydramine; Evaluation Studies as Topic; Forensic Pathology; Humans; Hydrocodone; Hydromorphone; Meperidine; Methadone; Morphine; Oxycodone; Oxymorphone; Pyrrolidines; Quality Control; Reproducibility of Results; Tandem Mass Spectrometry | 2014 |
Serotonin syndrome caused by drug to drug interaction between escitalopram and dextromethorphan.
Topics: Antitussive Agents; Citalopram; Cough; Depression; Dextromethorphan; Drug Interactions; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2017 |
Plasma Concentrations and Cardiovascular Effects of Citalopram Enantiomers After Oral Versus Infusion Citalopram Therapy in Dextromethorphan-Mephenytoin-Phenotyped Patients With Major Depression.
Topics: Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Dextromethorphan; Humans; Mephenytoin | 2021 |